an experimental experience

https://www.investors.com/news/technology/verv-stock-skyrockets-after-lilly-inks-deal-for-its-gene-editing-drugs/

10/31/23 at 2:04pm

Organization

Author

34 words

Comments

Eli Lilly now owns the opt-in rights to three more of Verve's cardiovascular drugs.

You are the first to view

Create an account or login to join the discussion